| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/07/1992 | US5079344 Monoclonal antibodies, hybridomas or cells |
| 01/07/1992 | US5079342 Diagnosis of AIDS |
| 01/07/1992 | US5079341 Antiinflammatory agents, antibody inhibitors |
| 01/07/1992 | US5079337 Transfusions of synthetic blood; nondiffusing from vascular systems; reversible oxygen carriers |
| 01/07/1992 | US5079336 α-1-antichymotrypsin, analogues and methods of production |
| 01/07/1992 | US5079231 Immunostimulating peptides, a process for their preparation and pharmaceutical compositions containing them |
| 01/07/1992 | US5079230 Stable bioactive somatotropins |
| 01/07/1992 | US5079229 Modified eglin proteins |
| 01/07/1992 | US5079228 Peptide inhibitors of neutrophil activating factor induced chemotaxis |
| 01/07/1992 | US5079156 Crosslinked Polyvinyl Acylate Polymers |
| 01/07/1992 | US5079129 Negative photoresist based on polyphenols and epoxy compounds or vinyl ethers |
| 01/07/1992 | US5078998 Hybrid ligand directed to activation of cytotoxic effector T lymphocytes and target associated antigen |
| 01/07/1992 | US5078997 Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers |
| 01/07/1992 | US5078996 Genetic engineering, anticancer agents |
| 01/07/1992 | US5078995 Fibrionolytic composition |
| 01/07/1992 | US5078985 Radiolabeling antibodies and other proteins with technetium or rhenium by regulated reduction |
| 01/07/1992 | US5078680 Automatic injector for emergency treatment |
| 01/07/1992 | CA2086761A1 Production of outer membrane (om) proteins in gram-positive bacteria and recovery of protective epitopes |
| 01/07/1992 | CA2086414A1 Retroviral protease inhibitors |
| 01/07/1992 | CA2086237A1 3-phenyl-5, 6-dihydrobenz¬c|acridine-7carboxylic acids and related compounds as immunosuppressive agents |
| 01/07/1992 | CA1294088C Chemically modified protein |
| 01/07/1992 | CA1293941C Method for preparing antihemophilic factor (ahf) by cold precipitation and for improving solubility of recovered ahf product |
| 01/07/1992 | CA1293940C Cdna clone for human tyrosinase |
| 01/06/1992 | CA2046112A1 Amino acid derivatives |
| 01/04/1992 | WO1992000767A1 Composition for stabilizing blood plasma during pasteurization |
| 01/04/1992 | CA2065284A1 Composition for stabilizing blood plasma during pasteurization |
| 01/03/1992 | WO1992000319A1 Human meg-csf protein and methods |
| 01/03/1992 | CA2086248A1 Human meg-csf protein and methods |
| 01/02/1992 | EP0464009A2 Oligopeptide derivatives of ipoxantine endowed with immunomodulating activity and pharmaceutical compositions containing same |
| 01/02/1992 | EP0463811A2 4-(4-Chlorophenylsulphonylcarbamoyl)benzoyl-L-valyl-L-proline-1-(RS)-(1-trifluoroacetyl-2-methylpropyl)amide for treating haemorrhage associated with acute non-lymphocytic leukaemia |
| 01/02/1992 | EP0463653A1 Galenic formulations containing cyclodextrins |
| 01/02/1992 | EP0463636A2 Cardiovascular composition |
| 01/02/1992 | EP0463615A1 Process for the production of GnRH-decapeptides |
| 01/02/1992 | EP0463450A1 Vasoactive intestinal polypeptide analogues and use thereof |
| 01/02/1992 | EP0463393A2 A mutant of bacillus subtiles and a method of producing surfactin with the use of the mutant |
| 01/02/1992 | EP0463154A1 Polypeptide and amino acid based composition |
| 01/02/1992 | EP0463126A1 Methods of enhancing wound healing and tissue repair |
| 01/02/1992 | EP0463115A1 Acetylated heterologous polypeptides. |
| 01/02/1992 | EP0463109A1 Recombinant alpha-galactosidase, a therapy for fabry disease |
| 01/02/1992 | EP0463082A1 Purified ciliary neurotrophic factor |
| 01/02/1992 | EP0463080A1 Cd8-based pharmaceuticals |
| 01/02/1992 | EP0463073A1 IMMUNOGLOBULIN A1 PROTEASES (IgA1 PROTEASES), METHOD OF GENE-TECHNOLOGICALLY PRODUCING THIS TYPE OF ENZYME AND VACCINES CONTAINING THE ENZYMES AND FRAGMENTS THEREOF FOR IMMUNIZING AGAINST BACTERIAL MENINGITIS AND OTHER DISEASES CAUSED BY IgA1 PROTEASE-PRODUCING BACTERIA |
| 01/02/1992 | EP0463072A1 Novel insulin compounds. |
| 01/02/1992 | EP0463059A1 Allergenic proteins from ragweed and uses therefor |
| 01/02/1992 | EP0463053A1 Production and use of anthelmintic agents and protective immunogens |
| 01/02/1992 | EP0463037A1 Human macrophage migration inhibitory factor |
| 01/02/1992 | EP0463004A1 Metabolic effects of leukaemia inhibitory factor on bone |
| 01/02/1992 | EP0451299A4 Magnetocontrollable carrier with physiologically active substance and method for making said carrier |
| 01/02/1992 | EP0196319B1 Retroviral polypeptides associated with human cellular transformation |
| 01/01/1992 | CN1015260B Perhydrothiazepine and perhydroazepine derivatives their preparation method |
| 12/31/1991 | US5077390 Cationic and anionic exchange chromatography |
| 12/31/1991 | US5077388 Purification of human interleukin-4 from a secreted escherichia coli mutant |
| 12/31/1991 | US5077285 Imidazole compounds and their use as transglutaminase inhibitors |
| 12/31/1991 | US5077276 Growth factor |
| 12/31/1991 | US5077220 Monoclonal antibody specific to a novel glycoprotein antigen on human carcinoma cells |
| 12/31/1991 | US5077216 Monoclonal antibodies specific for a human mononculear phagocyte-specific antigen |
| 12/31/1991 | US5077211 Purification and administration of dna repair enzymes |
| 12/31/1991 | US5077195 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor |
| 12/31/1991 | US5077193 Diagnostic kits |
| 12/31/1991 | CA2043618A1 Method for the production of gnrh-decapeptides |
| 12/31/1991 | CA1293839C Process for obtention of peptide amino-alcohol derivatives containing a tetrasubstituted carbon as inhibiting agents of renin and acid proteases |
| 12/30/1991 | WO1992000095A1 Histidine substituted growth hormone releasing factor analogs |
| 12/30/1991 | CA2085362A1 Histidine substituted growth hormone releasing factor analogs |
| 12/29/1991 | WO1992000375A1 Sex determining gene |
| 12/29/1991 | CA2085102A1 Sex determining gene |
| 12/29/1991 | CA2045008A1 Dipeptide derivatives |
| 12/28/1991 | CA2045073A1 Composition and treatment with biologically active peptides and antibiotics which inhibit dna gyrase |
| 12/27/1991 | WO1992000320A1 A process for the preparation of glutathione s-acyl derivatives, compounds obtained from said process and an intermediate useful for the preparation thereof |
| 12/27/1991 | WO1992000080A1 Method for treating leukemias |
| 12/27/1991 | EP0462960A1 Novel platelet-aggregation inhibitor |
| 12/27/1991 | EP0462959A1 Coated veterinary implants. |
| 12/27/1991 | EP0462884A1 TRH derivatives, their preparations and pharmaceutical compositions containing them |
| 12/27/1991 | EP0462792A2 Process for obtaining cellular protein having anti-HIV activity |
| 12/27/1991 | EP0462766A1 Composition useful in thrombolytic therapy |
| 12/27/1991 | EP0462721A2 Novel Bacillus thuringiensis microbes active against nematodes, and genes encoding novel nematode-active toxins cloned from Bacillus thuringiensis isolates |
| 12/27/1991 | EP0462651A1 Chimeric plasminogen activators |
| 12/27/1991 | EP0462631A1 Methods and compositions for the treatment of gastrointestinal disorders |
| 12/27/1991 | EP0462627A1 Antigens and peptides of lav. |
| 12/27/1991 | EP0462551A1 HIV GP120 monoclonal antibodies |
| 12/27/1991 | EP0462549A1 Process of preparing a therapeutic agent for renal diseases |
| 12/27/1991 | EP0462534A2 Acellular anti-pertussis vaccines |
| 12/27/1991 | EP0462531A2 Cyclic polypeptide with antibiotic activity, process for its preparation and pure culture of a Coelomycetes strain |
| 12/27/1991 | EP0462398A1 TGF-beta compositions |
| 12/27/1991 | EP0462305A1 Aerosol containing cytokines and use thereof |
| 12/27/1991 | EP0462291A1 Acat enzyme inhibiting composition |
| 12/27/1991 | EP0462277A1 Glycoprotein of human origin, physiologically active factor comprising the same, and pharmaceutical preparation containing the same as active ingredient |
| 12/27/1991 | EP0462229A1 Chemically modified cd4 peptide fragments having anti-retroviral properties |
| 12/27/1991 | EP0462215A1 MOLECULAR CLONING OF GENOMIC AND cDNA SEQUENCES ENCODING CELLULAR RECEPTORS FOR POLIOVIRUS |
| 12/27/1991 | EP0462207A1 Serpin resistant chymotrypsin superfamily proteases, particularly pai-1 resistant +-pa, complementary inhibitor mutants; compositions; genes; expression |
| 12/27/1991 | EP0462205A1 Leukocyte adhesion receptors |
| 12/27/1991 | EP0462192A1 Glycosylated insulins |
| 12/27/1991 | EP0462184A1 Method of treating viral infections using lfa-1 |
| 12/27/1991 | EP0462111A1 Homing sequences and their uses |
| 12/27/1991 | CA2086107A1 Process for the preparation of glutathione s-acyl derivatives, compounds obtained from said process and an intermediate useful for the preparation thereof |
| 12/27/1991 | CA2086105A1 Method for treating leukemias |
| 12/27/1991 | CA2045420A1 Peptides having atrial natriuretic factor activity |
| 12/26/1991 | WO1992000318A1 Tissue-derived tumor growth inhibitors, methods for preparation and uses thereof |
| 12/26/1991 | WO1991019803A1 Self assembled, defective, nonself-propagating viral particles |
| 12/26/1991 | WO1991019789A1 Endonucleases |
| 12/26/1991 | WO1991019787A1 Protease nexin-i variants |